Drug Profile
Cell cultured-derived adjuvanted influenza vaccine (Grippol TC) - AbbVie
Alternative Names: Grippol Neo; Grippol TC (cell-based adjuvanted seasonal vaccine) - AbbottLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Solvay Pharmaceuticals
- Developer AbbVie
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections